drugset / Trial / NCT01693042

Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure

NCT01693042 ↗

Phase 2/3 Unknown 81 enrolled Johann Wolfgang Goethe University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Single or repeated application of autologous bone marrow-derived stem cells to treat chronic post-infarction heart failure

Timeline

Start
2013-11
Primary completion
2022-11
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator autologous bone marrow-derived mononuclear cells Cell therapy — Other

Indications